Home › Funds › HBK INVESTMENTS L P › SOLV

HBK INVESTMENTS L P position in SOLV

SOLVENTUM CORP · Health Care

HBK INVESTMENTS L P reported holding 126,434 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$11.1M, representing 0.16% of its reported portfolio and ranking #46 among its reported holdings. HBK INVESTMENTS L P has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)126.43K sh
Reported value held$11.15M
Portfolio Weight0.16%
First reportedQ3 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How HBK INVESTMENTS L P's SOLV position evolved

HBK INVESTMENTS L P first disclosed a stake in SOLV in Q3 2024 at 183,917 shares (US$12.8M). The position peaked in Q4 2025 at 388,022 shares, worth US$30.7M. Across 9 filings, HBK INVESTMENTS L P increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 126,434 shares valued at US$11.1M — a reduction of -261,588 shares quarter over quarter.. Notable position changes include a 89% increase in Q4 2024 (shares rose 15% over the following quarter), a 67% trim in Q3 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 183.92K $12.82M New
Q4 2024 347.58K $22.96M Add
Q1 2025 347.65K $26.44M Hold
Q2 2025 361.98K $27.45M Add
Q3 2025 385.64K $28.15M Add
Q4 2025 388.02K $30.75M Add
Q1 2026 388.02K $25.34M Hold
Q2 2026 388.02K $29.94M Hold
Q3 2026 126.43K $11.15M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 39 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →

FAQ

How long has HBK INVESTMENTS L P held SOLV?

HBK INVESTMENTS L P has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is HBK INVESTMENTS L P's current position in SOLV?

As of Q3 2026, HBK INVESTMENTS L P holds 126.43K shares of SOLV (SOLVENTUM CORP), valued at $11.15M, representing 0.16% of its reported portfolio and ranking #46.

Has HBK INVESTMENTS L P been buying or selling SOLV?

In the latest 13F filing (Q3 2026), HBK INVESTMENTS L P reduced its position in SOLV. The position peaked in Q4 2025 at 388.02K shares.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.